Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
5.28
+0.05 (0.96%)
Nov 20, 2024, 4:00 PM EST - Market closed
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $124.90 million as of November 21, 2024. Its market cap has decreased by -5.31% in one year.
Market Cap
124.90M
Enterprise Value
125.60M
1-Year Change
-5.31%
Ranking
Category
Stock Price
$5.28
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has increased from $97.40M to $124.90M, an increase of 28.24%. That is a compound annual growth rate of 2.99%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 124.90M | 21.85% |
Dec 29, 2023 | 102.50M | -58.42% |
Dec 30, 2022 | 246.50M | -19.18% |
Dec 31, 2021 | 305.00M | 84.51% |
Dec 31, 2020 | 165.30M | 828.65% |
Dec 31, 2019 | 17.80M | -58.12% |
Dec 31, 2018 | 42.50M | 28.01% |
Dec 29, 2017 | 33.20M | -53.24% |
Dec 30, 2016 | 71.00M | -27.10% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Zomedica | 125.83M |
Compugen | 125.46M |
Avalo Therapeutics | 123.69M |
Context Therapeutics | 123.37M |
Repare Therapeutics | 123.28M |
Cibus | 123.00M |
Vigil Neuroscience | 122.71M |
Alto Neuroscience | 122.44M |